References
- Wagenmann A. Multiple neurome des auges und der Zunge. Ber Dtsch Opthalmol Ges. 1922;43:282–285.
- Morrison PJ, Nevin NC. Multiple endocrine neoplasia type 2B (mucosal neuroma syndrome, Wagenmann-Froboese syndrome). J Med Genet. 1996;33:7779–7782.
- Kennedy RA, Thavaraj S, Diaz-Cano S. An overview of autosomal dominant tumour syndromes with prominent features in the oral and maxillofacial region. Head Neck Pathol. 2017 [Epub ahead of print]. doi:10.1007/s12105-017-0778-1.
- Jacobs JM, Hawes MJ. From eyelid bumps to thyroid lumps: report of a MEN type IIb family and review of the literature. Ophthalmic Plast Reconstr Surg. 2001;17:195–201.
- Pappa T, Alevizaki M. Management of hereditary medullary thyroid carcinoma. Endocrine. 2016;53:7–17. doi:10.1007/s12020-016-0873-1.
- Carlson KM, Bracamontes J, Jackson CE, et al. Parent-of-origin effects in multiple endocrine neoplasia type 2B. Am J Hum Genet. 1994;55(6):1076–1082.
- Brauckhoff M, Machens A, Hess S, et al. Premonitory symptoms preceding metastatic medullary thyroid cancer in MEN 2B: an exploratory analysis. Surgery. 2008;144(6):1044–1050. doi:10.1016/j.surg.2008.08.028.
- Perros P, Boelaert K, Colley S, et al. Guidelines for the management of thyroid cancer. Clin Endocrinol (Oxf). 2014;81(s1):1–122.
- Schlumberger M, Elisei R, Muller S. Overall survival analysis of EXAM, a phase III trial of cabzantinib in patients with radiographically progressive medullary thyroid carcinoma. Ann Oncol 2017 1;28(11):2813–2819. doi:10.1093/annonc/mdx479.